Home Tags LOTIS 5

Tag: LOTIS 5

U.S. FDA Accepts Biologics License Application and Grants Priority Review for...

The U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for loncastuximab tesirine, previously known as ADCT-402. The investigational agent is...

X